Human medicines European public assessment report (EPAR): Abrysvo, Respiratory syncytial virus vaccines, Respiratory Syncytial ...
Abrysvo is a vaccine for protecting against lower respiratory tract disease (LRTD; diseases of the lungs such as bronchitis or pneumonia) caused by respiratory syncytial virus (RSV) in adults 60 years of age and older. It is also for use in mothers during …